Observational Study Collecting Blood Samples and Clinical Data to Improve Early Detection and Treatment of Lung Nodules Suspected for Cancer

What this Trial Is About

Researchers are conducting an observational study to improve early detection, confirmation, and treatment of lung cancer by finding the best combination of biomarkers and clinical data. The study focuses on people with lung nodules suspicious for cancer and aims to reduce cancer recurrence by identifying useful markers that can be easily collected and transported. This research is sponsored by Maverix Medical and does not affect patient care. Participants will provide peripheral blood samples and clinical information before any invasive diagnosis or treatment starts. The study includes three groups people with prior cancer, those with indeterminate lung nodules but no prior cancer, and healthy volunteers. The collected samples will undergo various analyses to find the most accurate and practical biomarkers for clinical use. During the study, participants will donate blood and share relevant medical data. Researchers will not report results back to treating physicians or alter patient care. The primary measure is test performance evaluated two years after the last participant enrolls. Participants involvement includes following planned medical procedures or surveillance for their nodules, and the study will track outcomes over time without impacting their usual treatment.

Specimens for Lung Cancer Panel Design